Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)

NCT00000621 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Emphysema
Lung Diseases
Lung Diseases, Obstructive
Chronic Obstructive Pulmonary Disease

Interventions

DRUG: all trans retinoic acid
DRUG: 13 cis retinoic acid
DRUG: placebo

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)